Bottom line
APHJX vs VXUS: the short answer
APHJX (Artisan International Small-Mid Fund) and VXUS (Vanguard Total International Stock Index Fund) are both mutual funds.
But VXUS is far broader, holding 8,868 positions to 121 for APHJX, so beyond the top names it adds exposure APHJX doesn't have.
VXUS is cheaper at 0.05% vs 1.08% — a difference of $103 a year per $10,000 invested.
Over five years, VXUS returned +8.0% a year vs +0.9% for APHJX.
Updated Nov 19, 2026
APHJX vs VXUS side by side
| APHJX | VXUS | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Artisan Partners | Vanguard |
| Category | International Stock | International Stock |
| Expense ratio | 1.08% | 0.05% |
| Annual cost per $10k | $108 | $5 |
| 10-yr cost on $10k (prospectus) | $1,317 | $64 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +18.6% | +32.3% |
| 5-yr return (annualized) | +0.9% | +8.0% |
| 10-yr return (annualized) | — | +8.6% |
| Best quarter | — | — |
| Worst quarter | — | — |
| Net assets (fund) | $2.5B | $645.9B |
| Number of holdings | 121 | 8,868 |
| Portfolio turnover | 34% | 4% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
APHJX and VXUS share none of their top holdings.
APHJX top 10
- LivaNova plc — 4.45%
- Metso Oyj — 3.79%
- Genmab A/S — 2.99%
- Brenntag SE — 2.50%
- Nice Ltd. — 2.40%
- Omron Corp. — 2.37%
- Kinaxis, Inc. — 2.24%
- Convatec Group plc — 2.14%
- Glanbia plc — 2.07%
- Money Forward, Inc. — 1.91%
VXUS top 10
- Taiwan Semiconductor Manufacturing Co Ltd — 4.10%
- Samsung Electronics Co Ltd — 1.83%
- Vanguard Cmt Funds-Vanguard Market Liquidity Fund — 1.66%
- ASML Holding NV — 1.45%
- SK hynix Inc — 1.43%
- Tencent Holdings Ltd — 0.87%
- HSBC Holdings PLC — 0.83%
- Vanguard Cmt Funds-Vanguard Market Liquidity Fund — 0.74%
- Roche Holding AG — 0.70%
- Royal Bank of Canada — 0.67%
FAQ
What is the difference between APHJX and VXUS?
Which is cheaper, APHJX or VXUS?
Should I own both APHJX and VXUS?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.